Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Medtronic
Merck
Moodys
Harvard Business School
Fuji
Julphar
QuintilesIMS
Novartis
Boehringer Ingelheim

Generated: December 11, 2017

DrugPatentWatch Database Preview

DICLOFENAC SODIUM AND MISOPROSTOL Drug Profile

« Back to Dashboard

When do Diclofenac Sodium And Misoprostol patents expire, and what generic alternatives are available?

Diclofenac Sodium And Misoprostol is a drug marketed by Actavis Labs Fl Inc, Amneal Pharms, Exela Holdings, and Sandoz. and is included in four NDAs.

The generic ingredient in DICLOFENAC SODIUM AND MISOPROSTOL is diclofenac sodium; misoprostol. There are forty-seven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the diclofenac sodium; misoprostol profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl IncDICLOFENAC SODIUM AND MISOPROSTOLdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL201089-001Jul 9, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozDICLOFENAC SODIUM AND MISOPROSTOLdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL200158-001May 9, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amneal PharmsDICLOFENAC SODIUM AND MISOPROSTOLdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL203995-002Nov 25, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozDICLOFENAC SODIUM AND MISOPROSTOLdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL200158-002May 9, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncDICLOFENAC SODIUM AND MISOPROSTOLdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL201089-002Jul 9, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amneal PharmsDICLOFENAC SODIUM AND MISOPROSTOLdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL203995-001Nov 25, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Exela HoldingsDICLOFENAC SODIUM AND MISOPROSTOLdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL200540-002Mar 14, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Exela HoldingsDICLOFENAC SODIUM AND MISOPROSTOLdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL200540-001Mar 14, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Healthtrust
US Army
UBS
Johnson and Johnson
Merck
QuintilesIMS
Fish and Richardson
Dow
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot